Pharmaceutical
| Mon 06 Apr 2026
Beijing, April 7 -- Hoffmann La Roche has sought patent for NLRP3 Inhibitors. This invention was developed by Aitken Linda Sue, Bush Lawrence A, Guba Wolfgang, Jaeschke Georg, Mesch Scott K, Schneider Christoph, Shannon Jonathan Martin and Steiner Stefan.
The patent application number is CN20248024552 20240410. The patent publi..